Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.63B P/E - EPS this Y -3.10% Ern Qtrly Grth -
Income -184.13M Forward P/E -10.32 EPS next Y 48.50% 50D Avg Chg -
Sales 237k PEG -2.28 EPS past 5Y - 200D Avg Chg 18.00%
Dividend N/A Price/Book 4.99 EPS next 5Y 5.00% 52W High Chg -17.00%
Recommedations 1.50 Quick Ratio 3.10 Shares Outstanding 588.06M 52W Low Chg 64.00%
Insider Own 0.09% ROA -41.47% Shares Float 475.07M Beta 0.61
Inst Own 67.85% ROE -112.29% Shares Shorted/Prior 46.66M/44.91M Price 3.20
Gross Margin - Profit Margin - Avg. Volume 5,610,301 Target Price 5.08
Oper. Margin -236,039.14% Earnings Date May 9 Volume 2,355,788 Change -0.31%
About Geron Corporation

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation News
04/11/24 Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
04/03/24 Geron to Participate at Upcoming Investor Conferences in April
04/01/24 5 FDA decisions to watch in the second quarter
03/21/24 Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
03/19/24 Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
03/15/24 Geron, Madrigal Pharmaceuticals jump on good news from FDA
03/15/24 Stocks to Watch Friday: Adobe, Ulta, Fisker
03/15/24 Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up
03/14/24 Geron Stock Is Soaring After Hours: What's Going On?
03/14/24 Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
03/14/24 UPDATE 3-Geron's blood disorder drug gets FDA advisers' backing
03/13/24 Implied Volatility Surging for Geron (GERN) Stock Options
03/12/24 UPDATE 3-US FDA staff raises concerns on Geron's blood disorder drug
03/01/24 Geron Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
02/29/24 Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript
02/28/24 Geron (GERN) Q4 2023 Earnings Call Transcript
02/28/24 Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
02/22/24 Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/14/24 Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
01/12/24 Geron to Participate in the B. Riley Securities Virtual Oncology Conference
GERN Chatroom

User Image ZoeyTanner Posted - 8 hours ago

$GERN Best on theboard..greatconference

User Image BioRich Posted - 8 hours ago


User Image Mail_Dog Posted - 10 hours ago

$GERN Gotta love it when millions of shorties run for cover..!!

User Image silversg3006 Posted - 11 hours ago

$GERN See that 25k buy pre mkt?? Good indicator

User Image Kimasztu Posted - 18 hours ago

$GERN shorts are trying really hard😂73% yesterday💪 but manage to still some more at 3.42😜

User Image PoorManRising Posted - 19 hours ago

@buymoremakemore see $GERN and $ARDX. Both in bad markets. $ARDX was in an even worse at the time.

User Image BrodieBody Posted - 1 day ago

$gern Analyst price target for today.🚀 amazing-stock-options.winning-trading-room.xyz

User Image Monist Posted - 2 days ago

$GERN 50¢

User Image bigmoneybilal Posted - 2 days ago

$GERN how soon after approval would you expect a buyout offer?

User Image ZoeyTanner Posted - 2 days ago

$GERN Prefunded warrants and 3 dollar stockselling by big funds.thanks a bunch chip.

User Image kimgysen Posted - 2 days ago

$GERN Eh what happened to Yahoo Finance? Where is my daily, weekly, monthly...

User Image SuzJensen Posted - 2 days ago

$GERN What else is new. Over the years, MASSIVE, 24-48 hour, drops in share price is oh so typical of Geron.

User Image Kimasztu Posted - 2 days ago

$GERN I set my buy on Friday at 3.56😂I was close but still have some powder to buy more when it drops to 3.3💪😎 All in🥳

User Image BubblesMcGee123 Posted - 3 days ago

$GERN Is the FDA in Big Pharma's pocket to some degree, or sometimes? Is the FDA magnifying and/or distorting minor issues with imetelstat so that when a buyout comes around Big Pharma can more easily push for a lower price?

User Image KingCryptoMan Posted - 3 days ago

$GERN Are we ready Gernites for the week ahead?

User Image FlynancialAnalyst Posted - 3 days ago

$GERN $2.14B mc $XBI name with a 5yr+ high wkly close on ramping wkly volume as fresh gold-cross crosses above now-rising secular SMA 67.9% institutionally owned, trending higher over the past 2 yrs. 👀👍📈💯

User Image Pastures Posted - 3 days ago

$GERN What price target are you hoping for in June?

User Image DiamondTrader83 Posted - 4 days ago

$GERN Look how things change in just one month, a new 52 week high of 4.05 on April 12 and still up over 100% from March 12 to April 12.

User Image StockInvest_us Posted - 4 days ago

Signal alert: $GERN - Overbought Trend Short (Overvalued) https://stockinvest.us/l/3feJooj7fH

User Image WaynD01 Posted - 5 days ago

$ZVRA The power of positive Adcom. The recent $GERN Adcom positive vote doubled the shae price and added another $1B to the market cap. And the beuty is that it is holding/improving on that price.

User Image kimgysen Posted - 5 days ago


User Image Marathonma Posted - 5 days ago

$GERN ATHE Huge P2 data release on Sunday 100% pop coning

User Image silversg3006 Posted - 5 days ago

$GERN Picked up another 100

User Image Mastermind94 Posted - 5 days ago


User Image nevermind889 Posted - 5 days ago

$GERN dang i wanan buy the dip! this market is poo poo!

User Image R408 Posted - 5 days ago

$GERN My only green stock

User Image Cancerkiller Posted - 5 days ago

$GERN once it breaks 4$ short sellers will see that gern hates 4 dollars. It likes 5 ans 6

User Image SuzJensen Posted - 5 days ago

$GERN Boy it hurts so BAD!

User Image KrytykyLMass Posted - 5 days ago

$GERN ffuuuuccckkkkk you shorties

User Image Mail_Dog Posted - 5 days ago

$GERN Not sure what JS & Co. are cooking in the kitchen but for now it appears…

Analyst Ratings
Needham Buy Apr 11, 24
Wedbush Outperform Apr 10, 24
Needham Buy Mar 15, 24
Goldman Sachs Buy Mar 15, 24
Wedbush Outperform Mar 15, 24
Needham Buy Mar 13, 24
Needham Buy Mar 12, 24
Needham Buy Mar 4, 24
Needham Buy Feb 28, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
O'Farrell Elizabeth G. Director Director Aug 24 Buy 2.28 13,186 30,064 26,220 08/24/23
LAWLIS V BRYAN Director Director May 11 Sell 3 35,000 105,000 05/11/23
LAWLIS V BRYAN Director Director May 11 Option 1.1 35,000 38,500 35,000 05/11/23
Molineaux Susan Director Director May 01 Sell 2.48 35,000 86,800 05/01/23
Molineaux Susan Director Director May 01 Option 1.1 35,000 38,500 35,000 05/01/23
GRETHLEIN ANDREW J EVP, Chief Operating.. EVP, Chief Operating Officer Feb 09 Sell 3.03 384,719 1,165,699 02/10/23
GRETHLEIN ANDREW J EVP, Chief Operating.. EVP, Chief Operating Officer Feb 09 Option 1.51 150,000 226,500 384,719 02/10/23
Bloom Olivia Kyusuk EVP, Chief Financial.. EVP, Chief Financial Officer Feb 08 Sell 3.08 400,000 1,232,000 74,588 02/10/23
Bloom Olivia Kyusuk EVP, Chief Financial.. EVP, Chief Financial Officer Feb 08 Option 1.51 400,000 604,000 474,588 02/10/23
SCARLETT JOHN A Chairman, President.. Chairman, President and CEO Feb 08 Sell 3.04 1,340,000 4,073,600 02/10/23
SCARLETT JOHN A Chairman, President.. Chairman, President and CEO Feb 08 Option 1.5 1,340,000 2,010,000 446,668 02/10/23
EASTHAM KARIN Director Director Jan 13 Option 1.10 35,000 38,500 109,047 01/17/23
GRETHLEIN ANDREW J EVP, Chief Operating.. EVP, Chief Operating Officer Sep 12 Option 1.7 234,719 399,022 234,719 09/14/22
EASTHAM KARIN Director Director Apr 20 Option 1.41 35,000 49,350 74,047 04/21/22